Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

    Home > Events > Veristat to exhibit at the dia euromeeting 2017

    1 min read

    Veristat to Exhibit at the DIA Euromeeting 2017

    DIA Euro Logo.pngJoin Veristat and nearly 2500 regulators, clinical, safety, and research professionals in health care and drug development from around the world at the 29th DIA Annual Euromeeting 2017.  
    Here we will discuss the biggest challenges, gain new insights and be inspired to accelerate the drug development and regulatory submission process.    All of this is centered around the meeting theme of "Translational Healthcare from Bench to Bedside - And Back."

    This is the first year that Veristat is participating in the DIA Annual Euroemeeting.   Just last year expanded our capabilities and service offering to Europe and we are excited to introduce Veristat at this meeting.

     

    Visit Our Booth #D12

    Veristat 2017 Tabletop Booth_Opt1000px.jpg

     

    Stop by our booth #D12 to meet Veristat, find out what we are all about and speak with our with our experts to talk about the challenges you are facing with your clinical trial design, execution and regulatory submission projects.   

     

    VivoActiv Watch.png

     

    And, don't forget to enter to win!   Each day during the afternoon refreshment break, we will raffle off a Garmin VivoActive Watch!    

    Enter to win daily!

     

    Schedule A Meeting

    Fill out the form on the right to schedule a specific time to meet with Veristat.   We will have staff from both the US as well as our European operations including our local Glasgow office.

    Share This Event:

       

    11 min read

    Monthly FDA Guidance and Regulatory News Review - September 2026

    This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...

    8 min read

    Monthly FDA Guidance and Regulatory News Review - August 2026

    This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...